Iron 관련 갑상선 저하 관련 체중 증가

Q: Does Iron help with 갑상선 저하 관련 체중 증가?

Based on 22 studies with 2,000 participants, there is limited but promising evidence that Iron may support 갑상선 저하 관련 체중 증가 management. Our evidence grade is C (Some Evidence).

Q: How much Iron should I take for 갑상선 저하 관련 체중 증가?

Studies have used various dosages. A commonly studied range is 8-18 mg/day (RDA). Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Iron?

Reported side effects may include Constipation, Nausea, Stomach pain, Black stools. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Iron and 갑상선 저하 관련 체중 증가?

We rate the evidence as Grade C (Some Evidence). This rating is based on 22 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

C 근거 소규모 연구에서의 근거는 제한적이지만, 일부 긍정적인 신호가 존재합니다.

Iron is required for thyroid peroxidase (TPO), and iron deficiency impairs T4-to-T3 conversion and thyroid hormone synthesis. Meta-analysis of 22 RCTs found correction of iron deficiency improves exercise tolerance and VO2max. Supplement only when deficiency is confirmed.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Diron\u0026condition\u003Dhypothyroid\u002Dweight\u002Dgain'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

결론

Key Study Findings

Retrospective cohort n=2851

Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single-Center Experience.

Dose: None vs: Placebo 효과: Ferritin low in 46.5% of patients; iron deficiency in 29.5% p<0.05

case-control study n=180

A comprehensive investigation of biochemical status in patients with telogen effluvium: Analysis of Hb, ferritin, …

Dose: not applicable vs: Placebo 효과: None None

Review

Impact of Vitamin D on Immunopathology of Hashimoto's Thyroiditis: From Theory to Practice.

Dose: Vitamin D vs: None Outcome: Thyroid autoimmunity modulation 효과: None None

대상 집단: Hashimoto's thyroiditis patients

Case-control n=100

The Association of Serum Ferritin Levels With Non-scarring Alopecia in Women.

Dose: None vs: Placebo 효과: MD=-7.40 (20.47 vs 27.87 µg/dL) p=0.005

Review

Role of Dietary Supplements in Thyroid Diseases.

Dose: None vs: None Outcome: None 효과: None None

대상 집단: Patients with thyroid diseases

Observational Study n=218

Retrospective evaluation of clinical profile and comorbidities in patients with alopecia areata.

Dose: None vs: AA patients without comorbidity Outcome: Clinical profile and comorbidities 효과: None p=0.008

대상 집단: Patients with alopecia areata (mean age 27.8y)

Key Statistics

연구

2000

참여자

↑

Positive

등급

Referenced Papers

Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single-Center Experience. Other

Journal of cosmetic … 2025 4 인용

A comprehensive investigation of biochemical status in patients with telogen effluvium: Analysis of Hb, ferritin, vitamin B12, vitamin D, thyroid … Other

Journal of cosmetic … 2024 7 인용

Impact of Vitamin D on Immunopathology of Hashimoto's Thyroiditis: From Theory to Practice. Review

Nutrients 2023 24 인용

Metabolic Characteristics of Hashimoto's Thyroiditis Patients and the Role of Microelements and Diet in the Disease Management-An Overview. Review

International journal of … 2022 102 인용

Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium. Other

Journal of cosmetic … 2022 22 인용

Role of Dietary Supplements in Thyroid Diseases. Review

Endocrine, metabolic & … 2022 8 인용

Retrospective evaluation of clinical profile and comorbidities in patients with alopecia areata. Other

Northern clinics of … 2022 7 인용

The Association of Serum Ferritin Levels With Non-scarring Alopecia in Women. Other

Cureus 2022 3 인용

The Potential Prebiotic Berberine Combined With Methimazole Improved the Therapeutic Effect of Graves' Disease Patients Through Regulating the Intestinal Microbiome. Other

Frontiers in immunology 2021 22 인용

Dietary supplements in hypothyroidism. Other

Acta scientiarum polonorum. … 2021 7 인용

NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India. Observational

Journal of cosmetic … 2019 25 인용

Methods of treatment patients with androgenetic alopecia based on reference of Department of Dermatology in Cracow. Other

Polski merkuriusz lekarski … 2019 4 인용

Multiple Nutritional Factors and the Risk of Hashimoto's Thyroiditis. Review

Thyroid : official … 2017 170 인용

A prospective case control questionnaire study for restless leg syndrome on 600 pregnant women. Other

The journal of … 2017 8 인용

Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center. Other

International journal of … 2016 28 인용

Clinicoepidemiological Observational Study of Acquired Alopecias in Females Correlating with Anemia and Thyroid Function. Other

Dermatology research and … 2016 26 인용

Evaluation and treatment of male and female pattern hair loss. Other

Journal of the … 2005 247 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:: 8-18 mg/day (RDA)
menstruatingwomen:: 18 mg/day
deficiencycorrection:: 100-200 mg elemental iron/day under medical guidance

상한량: 45 mg/day (elemental iron); excess iron increases oxidative stress

연구에서 사용된 용량

용량	기간	효과	N
None	--	Neutral	2851
not applicable	--	Mixed	180
Vitamin D	--	Positive	--
None	--	Negative	100
None	--	Mixed	--
None	--	Mixed	218
None	--	Positive	--
standard replacement doses	--	Neutral	3028

권장 복용 시간: On empty stomach with vitamin C for absorption; avoid with calcium, coffee, tea

Safety & Side Effects

보고된 부작용

⚠ Constipation
⚠ Nausea
⚠ Stomach pain
⚠ Black stools
⚠ Oxidative stress (excess iron)

알려진 상호작용

● Levothyroxine (reduced absorption — take 4 hours apart)
● Tetracycline antibiotics (reduced absorption)
● Calcium supplements (reduced absorption)
● Proton pump inhibitors (reduced absorption)

일일 최대 섭취 허용량: 45 mg/day (elemental iron); excess iron increases oxidative stress

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Iron help with 갑상선 저하 관련 체중 증가?

Based on 22 studies with 2,000 participants, there is limited but promising evidence that Iron may support 갑상선 저하 관련 체중 증가 management. Our evidence grade is C (Some Evidence).

How much Iron should I take for 갑상선 저하 관련 체중 증가?

Studies have used various dosages. A commonly studied range is 8-18 mg/day (RDA). Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Iron?

Reported side effects may include Constipation, Nausea, Stomach pain, Black stools. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Iron and 갑상선 저하 관련 체중 증가?

We rate the evidence as Grade C (Some Evidence). This rating is based on 22 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Iron 다른 건강 상태에 대한 근거

위 절제 수술 후 영양 지원 B 체중 감량을 위한 운동 수행력 C

한눈에 보기

Evidence Strength52%

Moderate confidence

연구 분석

RCT (0)Meta (0)Other (22)

대안 비교

이 건강 상태에 대한 다른 성분의 비교 결과를 확인하세요.

모든 성분 보기: 갑상선 저하 관련 체중 증가

자세히 알아보기

References

[1] Ömer Karakoyun et al.. J Cosmet Dermatol. 2025. Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single-Center Experience. doi:10.1111/jocd.70037 PubMed
[2] Irem Nur Durusu Turkoglu et al.. J Cosmet Dermatol. 2024. A comprehensive investigation of biochemical status in patients with telogen effluvium: Analysis of Hb, ferritin, vitamin B12, vitamin D, thyroid … doi:10.1111/jocd.16512 PubMed
[3] Filip Lebiedziński et al.. Nutrients. 2023. Impact of Vitamin D on Immunopathology of Hashimoto's Thyroiditis: From Theory to Practice. doi:10.3390/nu15143174 PubMed
[4] Aniceta A Mikulska et al.. Int J Mol Sci. 2022. Metabolic Characteristics of Hashimoto's Thyroiditis Patients and the Role of Microelements and Diet in the Disease Management-An Overview. doi:10.3390/ijms23126580 PubMed
[5] Ahu Yorulmaz et al.. J Cosmet Dermatol. 2022. Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium. doi:10.1111/jocd.14413 PubMed
[6] Vinesh Dahiya et al.. Endocr Metab Immune Disord Drug Targets. 2022. Role of Dietary Supplements in Thyroid Diseases. doi:10.2174/1871530322666220419125131 PubMed
[7] Sule Goksin. North Clin Istanb. 2022. Retrospective evaluation of clinical profile and comorbidities in patients with alopecia areata. doi:10.14744/nci.2022.78790 PubMed
[8] Muhammad Fawad Aslam et al.. Cureus. 2022. The Association of Serum Ferritin Levels With Non-scarring Alopecia in Women. doi:10.7759/cureus.32123 PubMed
[9] Zhe Han et al.. Front Immunol. 2021. The Potential Prebiotic Berberine Combined With Methimazole Improved the Therapeutic Effect of Graves' Disease Patients Through Regulating the Intestinal Microbiome. doi:10.3389/fimmu.2021.826067 PubMed
[10] Dagmara Woźniak et al.. Acta Sci Pol Technol Aliment. 2021. Dietary supplements in hypothyroidism. doi:10.17306/J.AFS.0985 PubMed
[11] Kavita Poonia et al.. J Cosmet Dermatol. 2019. NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India. doi:10.1111/jocd.12559 PubMed
[12] Karolina Kozicka et al.. Pol Merkur Lekarski. 2019. Methods of treatment patients with androgenetic alopecia based on reference of Department of Dermatology in Cracow. PubMed
[13] Shiqian Hu et al.. Thyroid. 2017. Multiple Nutritional Factors and the Risk of Hashimoto's Thyroiditis. doi:10.1089/thy.2016.0635 PubMed
[14] İrfan Ozer et al.. J Matern Fetal Neonatal Med. 2017. A prospective case control questionnaire study for restless leg syndrome on 600 pregnant women. doi:10.3109/14767058.2016.1170801 PubMed
[15] Tee Wei Siah et al.. Int J Trichology. 2016. Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center. doi:10.4103/0974-7753.188033 PubMed
[16] Kirti Deo et al.. Dermatol Res Pract. 2016. Clinicoepidemiological Observational Study of Acquired Alopecias in Females Correlating with Anemia and Thyroid Function. doi:10.1155/2016/6279108 PubMed
[17] Elise A Olsen et al.. J Am Acad Dermatol. 2005. Evaluation and treatment of male and female pattern hair loss. doi:10.1016/j.jaad.2004.04.008 PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.